Concepedia

Publication | Closed Access

Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study.

48

Citations

0

References

2002

Year

Nikolaos G. Papadopoulos, Yannis Alamanos, Ioannis Papadopoulos, Niki Tsifetaki, Paraskevi V. Voulgari, Alexandros A. Drosos
PubMed

Abstract

It appears that MTX has the longest survival time, with CSA following in second place. The main reasons for discontinuation of treatment were drug inefficacy, followed by adverse drug reactions.